We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.17B
1-Year Est. Return 92.19%
This Fund
S&P 500
This Quarter Est. Return
+32.88%
1 Year Est. Return
+92.19%
3 Year Est. Return
+240.57%
5 Year Est. Return
+377.11%
10 Year Est. Return
+3,179.38%
AUM
$1.17B
AUM Growth
+$68.7M
Cap. Flow
+$9.42M
Cap. Flow %
0.81%
Top 10 Hldgs %
33.9%
Holding
116
New
34
Increased
23
Reduced
41
Closed
18

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$26.9M
2
ASND icon
Ascendis Pharma A/S
ASND
+$19M
3
MTD icon
Mettler-Toledo International
MTD
+$16.1M
4
MRK icon
Merck
MRK
+$14.9M
5
CYTK icon
Cytokinetics
CYTK
+$13.8M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$50M
2
LLY icon
Eli Lilly
LLY
+$27.1M
3
PEN icon
Penumbra
PEN
+$25.8M
4
GKOS icon
Glaukos
GKOS
+$23.2M
5
CNTA
Centessa Pharmaceuticals
CNTA
+$21M

Sector Composition

Rank Sector Weight
1 Healthcare 98.83%
2 Miscellaneous 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAH icon
101
Cardinal Health
CAH
$57.5B
– –
-31,941
Closed -$6.75M
CNTA
102
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-528,224
Closed -$21M
DXCM icon
103
DexCom
DXCM
$33.2B
– –
-149,734
Closed -$9.4M
GKOS icon
104
Glaukos
GKOS
$10.5B
– –
-215,685
Closed -$23.2M
GMED icon
105
Globus Medical
GMED
$10.5B
– –
-16,923
Closed -$1.46M
HCA icon
106
PUT
HCA Healthcare
HCA
$87.7B
– –
-4,600
Closed -$2.18M
NEO icon
107
NeoGenomics
NEO
$2.23B
– –
-1,784,552
Closed -$13.2M
PSNL icon
108
Personalis
PSNL
$1.84B
– –
-870,097
Closed -$5.54M
SLNO
109
DELISTED
Soleno Therapeutics
SLNO
– –
-248,180
Closed -$8.31M
TERN
110
DELISTED
Terns Pharmaceuticals
TERN
– –
-172,962
Closed -$9.12M
UTHR icon
111
CALL
United Therapeutics
UTHR
$20.9B
– –
-31,700
Closed -$18.8M
UTHR icon
112
PUT
United Therapeutics
UTHR
$20.9B
– –
-45,900
Closed -$27.2M
XBI icon
113
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.7B
– –
-455,300
Closed -$58.2M
XLV icon
114
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$44.1B
– –
-238,900
Closed -$35M
BLLN
115
BillionToOne Inc
BLLN
$4.69B
– –
-88,069
Closed -$6.95M
MDLN
116
Medline Inc
MDLN
$32.1B
– –
-86,777
Closed -$3.86M
1 2 3 4
5

Similar funds

JC
Jacobs & Co San Francisco, California $1.17B AUM 37.3% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $1.16B AUM 40% 1-Year Est. Return
HCP
Hiddenite Capital Partners New York $1.16B AUM 95.58% 1-Year Est. Return
EC
Estate Counselors Thiensville, Wisconsin $1.16B AUM 21.97% 1-Year Est. Return
M
MOTCO San Antonio, Texas $1.17B AUM 23.84% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
VFP
Verus Financial Partners Richmond, Virginia $1.17B AUM 15.91% 1-Year Est. Return

PFM Health Sciences's Q2 2026 Portfolio in Review

As of Q2 2026, PFM Health Sciences held 116 positions worth $1.17B, up 6.3% from $1.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

PFM Health Sciences's Q2 2026 filing shows 34 new, 23 increased, 41 reduced and 18 closed positions. Its largest new stake was Humana: 94,375 shares worth $37.5M. The largest sale was Tenet Healthcare, an estimated $50M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 85% a quarter earlier, followed by Miscellaneous.

  • PFM Health Sciences's largest Q2 2026 buy was Humana: 94,375 shares worth $37.5M.
  • PFM Health Sciences added most to Ascendis Pharma A/S in Q2 2026, an estimated $19M increase.
  • PFM Health Sciences's biggest Q2 2026 reduction was Tenet Healthcare, cutting an estimated $50M.
  • PFM Health Sciences fully exited Glaukos in Q2 2026, selling an estimated $23.2M.
  • PFM Health Sciences's ten largest holdings make up 34% of its $1.17B portfolio in Q2 2026.
  • PFM Health Sciences opened 34 new positions and closed 18 in Q2 2026.
  • PFM Health Sciences's portfolio value rose 6.3% quarter-over-quarter to $1.17B.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.